文献速递脑血管病

短期双联抗血小板治疗与阿司匹林单药在卒中或TIA患者中的比较:随机对照试验荟萃分析

Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials.
PubMed 文献 · Stroke · 2021-04-27

结果显示DAPT降低复发性卒中风险(RR 0.76,95%CI 0.68–0.83),但增加大出血风险(RR 2.22,95%CI 1.14–4.34)。

要点

  • 短期DAPT降低复发性卒中风险(RR 0.76,95%CI 0.68–0.83)。
  • 短期DAPT增加大出血风险(RR 2.22,95%CI 1.14–4.34)。
  • 高危TIA或轻中度缺血性卒中24小时内启动DAPT可获益。

核心结论

  • 与阿司匹林单药相比,高危TIA或轻中度缺血性卒中24小时内启动短期DAPT降低复发性卒中风险,但增加大出血风险。

研究设计与样本

  • 比较早期启动短期DAPT(阿司匹林+P2Y12抑制剂,最长3个月)与阿司匹林单药。

主要发现

  • DAPT组复发性卒中风险低于阿司匹林单药组(RR 0.76,95%CI 0.68–0.83;P<0.001;I2=0%)。
  • DAPT组大出血事件风险高于阿司匹林单药组(RR 2.22,95%CI 1.14–4.34;P=0.02;I2=46.5%)。
  • DAPT组主要不良心血管事件风险较低(RR 0.76,95%CI 0.69–0.84;P<0.001;I2=0%)。
  • DAPT组复发性缺血事件风险较低(RR 0.74,95%CI 0.67–0.82;P<0.001;I2=0%)。

临床怎么用

  • 对高危TIA或轻中度缺血性卒中患者,可考虑在24小时内启动短期DAPT以降低复发性卒中风险。
  • 启动DAPT时需权衡大出血风险,个体化评估出血风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Antiplatelet therapy is key for preventing thrombotic events after transient ischemic attack or ischemic stroke. Although the role of aspirin is well established, there is emerging evidence for the role of short-term dual antiplatelet therapy (DAPT) in preventing recurrent stroke. METHODS: We conducted a systematic review and study-level meta-analyses of randomized controlled trials comparing outcomes of early initiation of short-term DAPT (aspirin+P2Y12 inhibitor for up to 3 months) versus aspirin alone in patients with acute stroke or transient ischemic attack. Primary efficacy outcome was risk of recurrent stroke and primary safety outcome was incidence of major bleeding. Secondary outcomes studied were risk of any ischemic stroke, hemorrhagic stroke, major adverse cardiovascular events, and all-cause death. Pooled risk ratios (RRs) and CIs were calculated using a random-effects model. RESULTS: Four trials with a total of 21 459 patients were included. As compared to aspirin alone, DAPT had a lower risk of recurrent stroke (RR, 0.76 [95% CI, 0.68–0.83]; P<0.001; I2=0%) but a higher risk of major bleeding events (RR, 2.22 [95% CI, 1.14–4.34], P=0.02, I2=46.5%). Patients receiving DAPT had a lower risk of major adverse cardiovascular events (RR, 0.76 [95% CI, 0.69–0.84], P<0.001, I2=0%) and recurrent ischemic events (RR, 0.74 [95% CI, 0.67–0.82], P<0.001, I2=0%). CONCLUSIONS: As compared to aspirin alone, short-term DAPT within 24 hours of high-risk transient ischemic attack or mild-moderate ischemic stroke reduces the risk of recurrent stroke at the expense of higher risk of major bleeding.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Bhatia K, Jain V, Aggarwal D, et al. Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials. Stroke. 2021. PMID: 33902301. doi:10.1161/STROKEAHA.120.033033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。